Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.310
-0.052 (-3.85%)
At close: May 30, 2025, 4:00 PM
1.320
+0.010 (0.76%)
After-hours: May 30, 2025, 4:04 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $25.10 million as of May 30, 2025. Its market cap has increased by 116.90% in one year.
Market Cap
25.10M
Enterprise Value
15.31M
1-Year Change
116.90%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $25.10M, a decrease of -96.02%. That is a compound annual growth rate of -53.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 29, 2025 | 26.11M | -23.50% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 645.82B |
| Johnson & Johnson | 366.76B |
| AbbVie | 323.41B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 270.43B |
| Abbott Laboratories | 229.69B |
| Novartis AG | 219.70B |
| AstraZeneca | 216.88B |